Factors influencing the prevalence and severity of tardive dyskinesia
- PMID: 6144133
Item in Clipboard
Factors influencing the prevalence and severity of tardive dyskinesia
Psychopharmacol Bull.
1984 Winter.
No abstract available
Similar articles
-
Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.J Clin Psychiatry. 2003 Nov;64(11):1342-8. J Clin Psychiatry. 2003. PMID: 14658949 Clinical Trial.
-
Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.J Clin Psychiatry. 2004;65 Suppl 9:16-20. J Clin Psychiatry. 2004. PMID: 15189107 Review.
-
Tardive dyskinesia: changes after three years.J Clin Psychopharmacol. 1983 Oct;3(5):315-8. J Clin Psychopharmacol. 1983. PMID: 6138371 No abstract available.
-
Clozapine-induced tardive dyskinesia: a case report.Prog Neuropsychopharmacol Biol Psychiatry. 2005 May;29(4):633-5. doi: 10.1016/j.pnpbp.2005.01.014. Prog Neuropsychopharmacol Biol Psychiatry. 2005. PMID: 15866369
-
[Tardive dyskinesia: etiology, clinical features and therapy].Harefuah. 2001 Mar;140(3):248-52. Harefuah. 2001. PMID: 11303354 Review. Hebrew. No abstract available.
Cited by
-
Effect of extended depot fluphenazine treatment and withdrawal on social and other behaviors of Cebus apella monkeys.Psychopharmacology (Berl). 1991;105(4):492-500. doi: 10.1007/BF02244369. Psychopharmacology (Berl). 1991. PMID: 1771217